OTLK Next Earnings Date Notes

— Outlook Therapeutics (ticker: OTLK) is a late clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, an ophthalmic formulation of bevacizumab (an anti-VEGF antibody) for use in treating retinal diseases like wet AMD and diabetic macular edema. Their main aim is to provide the first FDA-approved ophthalmic bevacizumab, which would address the current off-label use and possibly gain preferential reimbursement & market access. As an investor listening to the next OTLK earnings call, the most crucial business metrics to track are regulatory milestones (especially FDA or EMA feedback & approvals), the progress & timelines of clinical studies, partnership developments, and cash runway or burn rate. Additionally, watch for management's updates on potential commercialization plans, market size projections for ONS-5010, and feedback from healthcare providers & payers, as these will shape OTLK's long-term growth potential. Revenue won’t likely be a factor until regulatory clearance is achieved, so emphasis is on approval path clarity, partnership traction, and financial sustainability. The next projected earnings date for OTLK is 8/13/2026 8:00 am (stay tuned for a confirmed earnings date once announced).

OTLK Next Earnings Date FAQ

On this page we presented the OTLK Next Earnings Date information for Outlook Therapeutics along with recent past earnings dates. For Q2 of 2026, OTLK reported earnings of -0.160/share, with the earnings report taking place on 5/15/2026. For Q1 of 2026, OTLK reported earnings of -0.220/share, with the earnings report taking place on 2/17/2026. For Q4 of 2025, OTLK reported earnings of -0.190/share, with the earnings report taking place on 12/19/2025. For Q3 of 2025, OTLK reported earnings of -0.440/share, with the earnings report taking place on 8/14/2025. For Q2 of 2025, OTLK reported earnings of -0.400/share, with the earnings report taking place on 5/15/2025. Based on these past earnings dates, the projected next earnings date for OTLK is 8/13/2026 8:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Outlook Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Outlook Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Outlook Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next OTLK earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up OTLK's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the OTLK next earnings date.